GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
42 hedge funds and large institutions have $86.3M invested in Genocea Biosciences, Inc. in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 39 → 42 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
42
Holding in Top 10
2
Calls
$4.26M
Puts
$390K
Top Buyers
| 1 | +$3M | |
| 2 | +$525K | |
| 3 | +$271K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$213K |
| 5 |
Two Sigma Investments
New York
|
+$108K |
Top Sellers
| 1 | -$2.45M | |
| 2 | -$1.01M | |
| 3 | -$429K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$135K |
| 5 |
Capstone Investment Advisors
New York
|
-$67K |